SEARCH HEALTH CONDITIONS BY ALPHABETS
Nausea/Vomiting, Postoperative
Medications for Nausea/Vomiting, Post-operative
Around Nausea/Vomiting, Postoperative: Nausea and vomiting occurring following a surgical operation.
Drugs Used in the Treatment of Nausea/Vomiting, Post-operative
This set of medications are found in the treating this particular condition, or in some way related to.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| ondansetron | Rx | B | N | 11 testimonials | 8.0 | ||
Generic title: ondansetron systemic Brand names: Zofran, Zofran ODT, Zuplenz Medicine course: 5HT3 receptor antagonists For users: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Zofran | Rx | B | N | 5 testimonials | 7.9 | ||
Generic title: ondansetron systemic Medicine course: 5HT3 receptor antagonists For users: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Reglan | Rx | B | N | X | Two testimonials | 7.0 | |
Generic title: metoclopramide systemic Medicine category: GI stimulants, miscellaneous Anti-emetics For users: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| metoclopramide | Rx | B | N | X | Two testimonials | 7.8 | |
Generic title: metoclopramide systemic Brand title: Reglan Medicine category: GI stimulants, miscellaneous Anti-emetics For users: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Zofran ODT | Rx | B | N | 1 review | 10 | ||
Generic title: ondansetron systemic Medicine course: 5HT3 receptor antagonists For users: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
| Emend | Rx | B | N | Two testimonials | 10 | ||
Generic title: aprepitant systemic Medicine course: NK1 receptor antagonists For users: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| aprepitant | Rx | B | N | Two testimonials | 10 | ||
Generic title: aprepitant systemic Brand title: Emend Medicine course: NK1 receptor antagonists For users: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| droperidol | Rx | C | N | X | Add review | 0.0 | |
Generic title: droperidol systemic Brand title: Inapsine Drug class: miscellaneous central nervous system representatives For users: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Zuplenz | Rx | B | N | Add review | 0.0 | ||
Generic title: ondansetron systemic Medicine course: 5HT3 receptor antagonists For users: dosage, interactions, and side effects For specialists: Prescribing Information | |||||||
| granisetron | Rx | B | N | Two testimonials | 10 | ||
Generic title: granisetron systemic Medicine course: 5HT3 receptor antagonists For users: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Inapsine | Rx | C | N | X | Add review | 0.0 | |
Generic title: droperidol systemic Drug class: miscellaneous central nervous system representatives For users: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Aloxi | Rx | B | N | 1 review | 10 | ||
Generic title: palonosetron systemic Medicine course: 5HT3 receptor antagonists For users: dosage, interactions, and side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| palonosetron | Rx | B | N | 1 review | 10 | ||
Generic title: palonosetron systemic Brand title: Aloxi Medicine course: 5HT3 receptor antagonists For users: dosage, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over The Counter |
| Off Label | This medication may not be approved by the FDA for treating this particular condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the embryo in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal research studies have demonstrated an adverse effect in the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in used in elderly women clearly outweigh potential rewards. |
| N | FDA has not classified the medication. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| 1 | includes a high potential for misuse. Has no accepted medical use in treatment in the USA. There`s a lack of accepted safety for use under medical supervision. |
| Two | includes a high potential for misuse. Has a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Abuse may result in acute psychological or physical dependence. |
| 3 | features a possibility for abuse less than those in programs 1 and 2 2. Has a currently accepted medical use in treatment in the USA. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a low potential for abuse in accordance with those in program 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to those in program 3. |
| 5 | includes a low potential for abuse in accordance with those in program 4. Has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence. |
| Alcohol | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always ask your healthcare provider to be sure the information pertains to your circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
